1,000
Participants
Start Date
April 30, 2013
Primary Completion Date
April 30, 2021
Study Completion Date
April 30, 2026
Pharmacogenomics
"Blood samples (2x5ml EDTA tubes) should be collected just before the start of the conditioning regimen from every patient regardless of therapeutic arm by every centre and stored ≤-20°C Patient should be in remission (MRD negative) for this sampling, otherwise the sample should be taken using a mouth swab/saliva (not intravenously).~For second transplant patients, please provide DNA taken before first transplant or a fresh saliva samples."
Busulfan plasma level measurements
"Bu PK analysis after the first dose of IV Bu (+potential subsequent ones).~Blood sampling:~-\>For Bu 4 X/d: Before the first Bu dose (Time 0), then straight after the end of infusion (Time 1), then at 15 min (Time 2), 30 min (Time 3), 1 hour (Time 4) and 4 hour (Time 5) after the end of infusion~-\>For Bu 1 X/d: Before the first Bu dose (Time 0), then straight after the end of infusion (Time 1), then at 1 hour (Time 2), 3 hour (Time 3), 5 hour (Time 4), 7 hour (Time 5) and 11 hour (Time 6) after the end of infusion.~For centers not performing BU TDM, perform Dried Blood Sampling (DBS) analysis:~-\> 0.5ml blood sample should be collected and 5µl spotted onto DBS cards in duplicate. Dry them max 5 hours and then keep in a sealed envelope and store at -80°C, as below"
RECRUITING
Hôpital Cantonal de Genève, Département de Pédiatrie, Geneva
RECRUITING
HUG Hôpitaux Universitaire de Genève, Unité d'onco-hématologie pédiatrique, Geneva
RECRUITING
Universitäts-Kinderspital beider Basel (UKBB), Onkologie/Hämatologie, Basel
RECRUITING
Universitäts-Kinderspital, Zurich
ALL SCTped Forum
OTHER
Swiss Pediatric Oncology Group
OTHER